These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 4396422)

  • 1. [Effects of thioproperazine on dopamine and noradrenaline metabolism in chronic schizophrenia].
    Panisset VC; Albert JM; Rocheleau LP; Dhaiti G; Tétreault L
    Laval Med; 1970 Sep; 41(7):917-22. PubMed ID: 4396422
    [No Abstract]   [Full Text] [Related]  

  • 2. [Effects of thioproperazine on the urinary excretion and concentration in the cerebrospinal fluid of 5-hydroxyindoleacetic acid in chronic schizophrenia].
    Albert JM; Palaic D; Tétreault L; Panisset JC; Dhaiti G; Desaty J
    Laval Med; 1971 Feb; 42(2):167-71. PubMed ID: 4396038
    [No Abstract]   [Full Text] [Related]  

  • 3. Taste sensitivity and the appearance of phenothiazine-tranquilizer induced extrapyramidal symptoms.
    Fischer R; Knopp W; Griffin F
    Arzneimittelforschung; 1965 Dec; 15(12):1379-82. PubMed ID: 5899813
    [No Abstract]   [Full Text] [Related]  

  • 4. Homovanillic acid in the ventricular fluid of patients with Parkinson's disease and other extrapyramidal diseases.
    Papeschi R; Molina-Negro P; Sourkes TL; Hardy J; Bertrand C
    Laval Med; 1970 Sep; 41(7):899-901. PubMed ID: 5509486
    [No Abstract]   [Full Text] [Related]  

  • 5. Drug-induced extrapyramidal disorders.
    Chase TN
    Res Publ Assoc Res Nerv Ment Dis; 1972; 50():448-71. PubMed ID: 4341954
    [No Abstract]   [Full Text] [Related]  

  • 6. [Some unusual extrapyramidal complications of psychopharmacotherapy].
    Baudis P; Paceltová L
    Cesk Psychiatr; 1969 Dec; 65(6):390-4. PubMed ID: 5362977
    [No Abstract]   [Full Text] [Related]  

  • 7. Thioproperazine ("Majeptil"), therapeutic results and complications in 63 patients with functional psychoses.
    Lien JB
    Acta Psychiatr Scand; 1967; 43(3):318-40. PubMed ID: 4385555
    [No Abstract]   [Full Text] [Related]  

  • 8. [A chronic extrapyramidal syndrome as a complication of neuroleptic therapy].
    Gurovich IIa; Fleĭs EP
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1969; 69(12):1862-8. PubMed ID: 5375563
    [No Abstract]   [Full Text] [Related]  

  • 9. Norepinephrine and dopamine in the corpus striatum and remainder of the brain following phenothiazine treatment.
    Angelakos ET; McKenna OC
    Arch Int Pharmacodyn Ther; 1965 Oct; 157(2):288-92. PubMed ID: 5895686
    [No Abstract]   [Full Text] [Related]  

  • 10. [Symptoms of the extrapyramidal syndrome during maintenence therapy with neuroleptic drugs].
    Sujecka-Szymkiewicz H
    Psychiatr Pol; 1967; 1(1):79-84. PubMed ID: 4876412
    [No Abstract]   [Full Text] [Related]  

  • 11. Extrapyramidal disorders after prolonged phenothiazine therapy.
    Kennedy PF; Hershon HI; McGuire RJ
    Br J Psychiatry; 1971 May; 118(546):509-18. PubMed ID: 5580366
    [No Abstract]   [Full Text] [Related]  

  • 12. Effect of thioproperazine on 5-HIAA content in urine and cerebrospinal fluid of chronic schizophrenic patients.
    Albert JM; Palaic D; Tetreault L; Panisset JC DHAITI G; Desaty J
    Dis Nerv Syst; 1970 Nov; 31():Suppl:140-4. PubMed ID: 4395198
    [No Abstract]   [Full Text] [Related]  

  • 13. [Biochemistry and treatment of Parkinson's disease].
    Barbeau A
    Laval Med; 1970 Sep; 41(7):902-5. PubMed ID: 5509487
    [No Abstract]   [Full Text] [Related]  

  • 14. [On the problem of fixed extrapyramidal disorders following prolonged use of neuroleptics].
    Krystof J; Kajzer J
    Psychiatr Pol; 1967; 1(3):289-93. PubMed ID: 5593256
    [No Abstract]   [Full Text] [Related]  

  • 15. [Extrapyramidal syndrome in animal experiments: rôle of calcium and o-methylated derivatives].
    Radouco-Thomas S
    Laval Med; 1970 Sep; 41(7):886-93. PubMed ID: 5515480
    [No Abstract]   [Full Text] [Related]  

  • 16. [Late irreversible extrapyramidal syndrome following neuroleptic use].
    Boucebci M
    Acta Psychiatr Belg; 1972 Mar; 72(2):233-40. PubMed ID: 5056017
    [No Abstract]   [Full Text] [Related]  

  • 17. Action of L-Dopa in drug induced extrapyramidalism.
    Yaryura-Tobias JA; Wolpert A; Dana L; Merlis S
    Dis Nerv Syst; 1970 Jan; 31(1):60-3. PubMed ID: 5413729
    [No Abstract]   [Full Text] [Related]  

  • 18. [Comparative study of 2 drugs and a placebo in chronic schizophrenia].
    Tetreault L
    Actual Pharmacol (Paris); 1969; 22():1-18. PubMed ID: 4927120
    [No Abstract]   [Full Text] [Related]  

  • 19. Effects of drug withdrawal on tardive dyskinesia.
    Crane GE; Ruiz P; Kernohan WJ; Wilson W; Royalty N
    Act Nerv Super (Praha); 1969; 11(1):30-5. PubMed ID: 5770140
    [No Abstract]   [Full Text] [Related]  

  • 20. Extra pyramidal manifestations following phenothiazines therapy. Report of 10 cases with review of Indian literature.
    Mittal MM; Gupta SK; Misra RC
    J Assoc Physicians India; 1970 Aug; 18(8):691-6. PubMed ID: 5480839
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.